Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study.

Matsubara T, Naruse K, Arakawa T, Nakao M, Yokoi K, Oguri M, Marui N, Amano T, Ichimiya S, Ohashi T, Imai K, Sakai S, Sugiyama S, Ishii H, Murohara T.

J Cardiol. 2012 Nov;60(5):389-94. doi: 10.1016/j.jjcc.2012.07.012. Epub 2012 Aug 11.

2.

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.

Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.

Clin Ther. 2007 Nov;29(11):2365-73.

PMID:
18158077
3.
4.

Effects of pitavastatin on adiponectin in patients with hyperlipidemia.

Inami N, Nomura S, Shouzu A, Omoto S, Kimura Y, Takahashi N, Tanaka A, Nanba M, Shouda Y, Iwasaka T.

Pathophysiol Haemost Thromb. 2007;36(1):1-8. doi: 10.1159/000112633. Epub 2008 Mar 6.

PMID:
18332608
5.

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.

Simons L, Tonkon M, Masana L, Maccubbin D, Shah A, Lee M, Gumbiner B.

Curr Med Res Opin. 2004 Sep;20(9):1437-45.

PMID:
15383192
6.

Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.

Kurogi K, Sugiyama S, Sakamoto K, Tayama S, Nakamura S, Biwa T, Matsui K, Ogawa H; COMPACT-CAD Investigators.

J Cardiol. 2013 Aug;62(2):87-94. doi: 10.1016/j.jjcc.2013.03.008. Epub 2013 May 11.

7.

Pitavastatin: an overview.

Saito Y.

Atheroscler Suppl. 2011 Nov;12(3):271-6. doi: 10.1016/S1567-5688(11)70886-8. Review.

PMID:
22152281
8.

Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonists.

Yoshika M, Komiyama Y, Masuda M, Yokoi T, Masaki H, Ohkura H, Takahashi H.

Clin Exp Hypertens. 2010;32(6):341-6. doi: 10.3109/10641961003628460.

PMID:
21028996
9.

Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatin.

Tani S, Takahashi A, Nagao K, Hirayama A.

Heart Vessels. 2015 Nov;30(6):762-70. doi: 10.1007/s00380-014-0554-z. Epub 2014 Jul 26.

PMID:
25062713
10.

Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars.

Koshiyama H, Taniguchi A, Tanaka K, Kagimoto S, Fujioka Y, Hirata K, Nakamura Y, Iwakura A, Hara K, Yamamoto T, Kuroe A, Ohya M, Fujimoto S, Hamamoto Y, Honjo S, Ikeda H, Nabe K, Tsuda K, Inagaki N, Seino Y, Kume N; Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology Investigators.

J Atheroscler Thromb. 2008 Dec;15(6):345-50. Epub 2008 Dec 11.

11.

The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.

Nomura S, Inami N, Shouzu A, Omoto S, Kimura Y, Takahashi N, Tanaka A, Urase F, Maeda Y, Ohtani H, Iwasaka T.

Platelets. 2009 Feb;20(1):16-22. doi: 10.1080/09537100802409921.

PMID:
19172517
12.

Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.

da Silva PM.

Am J Cardiovasc Drugs. 2011;11(2):93-107. doi: 10.2165/11591190-000000000-00000. Review.

PMID:
21446776
13.
14.

Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients.

Nomura S, Shouzu A, Omoto S, Inami N, Shimazu T, Satoh D, Kajiura T, Yamada K, Urase F, Maeda Y, Iwasaka T.

Blood Coagul Fibrinolysis. 2009 Sep;20(6):440-7. doi: 10.1097/MBC.0b013e32832e0618.

PMID:
19525846
15.

Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia.

Teramoto T, Shimano H, Yokote K, Urashima M.

J Atheroscler Thromb. 2009 Oct;16(5):654-61.

17.

Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.

Yee LL, Wright EA.

Clin Ther. 2011 Aug;33(8):1023-42. doi: 10.1016/j.clinthera.2011.07.011. Epub 2011 Aug 4. Review.

PMID:
21816477
18.

Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels.

Horiuchi Y, Hirayama S, Soda S, Seino U, Kon M, Ueno T, Idei M, Hanyu O, Tsuda T, Ohmura H, Miida T.

J Atheroscler Thromb. 2010 Jul 30;17(7):722-9. Epub 2010 Jun 2.

19.

Usefulness of C-reactive protein to high-molecular-weight adiponectin ratio to predict insulin resistance and metabolic syndrome in Japanese men.

Saisho Y, Hirose H, Seino Y, Saito I, Itoh H.

J Atheroscler Thromb. 2010 Sep 30;17(9):944-52. Epub 2010 Jun 11.

20.

The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study.

Sakamoto K, Sakamoto T, Ogawa H; Kumamoto Joint Research on Hypercholesterolemia Investigators.

Clin Ther. 2006 Jul;28(7):1012-21.

PMID:
16990079

Supplemental Content

Support Center